| Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis MP Curry, JG O’Leary, N Bzowej, AJ Muir, KM Korenblat, JM Fenkel, ... New England Journal of Medicine 373 (27), 2618-2628, 2015 | 977 | 2015 |
| Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ... Gastroenterology 149 (3), 649-659, 2015 | 955 | 2015 |
| Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection M Bourlière, SC Gordon, SL Flamm, CL Cooper, A Ramji, M Tong, ... New England Journal of Medicine 376 (22), 2134-2146, 2017 | 707 | 2017 |
| Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study MP Curry, X Forns, RT Chung, NA Terrault, R Brown Jr, JM Fenkel, ... Gastroenterology 148 (1), 100-107. e1, 2015 | 483* | 2015 |
| Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation M Charlton, E Gane, MP Manns, RS Brown Jr, MP Curry, PY Kwo, ... Gastroenterology 148 (1), 108-117, 2015 | 478* | 2015 |
| The clinical significance of persistently normal ALT in chronic hepatitis B infection M Lai, BJ Hyatt, I Nasser, M Curry, NH Afdhal Journal of hepatology 47 (6), 760-767, 2007 | 464 | 2007 |
| Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome F Wong, SC Pappas, MP Curry, KR Reddy, RA Rubin, MK Porayko, ... New England Journal of Medicine 384 (9), 818-828, 2021 | 341 | 2021 |
| Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source SM McKiernan, R Hagan, M Curry, GSA McDonald, A Kelly, N Nolan, ... Hepatology 40 (1), 108-114, 2004 | 341 | 2004 |
| CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons AJ MacDonald, M Duffy, MT Brady, S McKiernan, W Hall, J Hegarty, ... The Journal of infectious diseases 185 (6), 720-727, 2002 | 339 | 2002 |
| The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation J Levitsky, RN Formica, RD Bloom, M Charlton, M Curry, J Friedewald, ... American Journal of Transplantation 17 (11), 2790-2802, 2017 | 323 | 2017 |
| Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1 TD Boyer, AJ Sanyal, F Wong, RT Frederick, JR Lake, JG O’Leary, ... Gastroenterology 150 (7), 1579-1589. e2, 2016 | 323 | 2016 |
| Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation X Forns, M Charlton, J Denning, JG McHutchison, WT Symonds, ... Hepatology 61 (5), 1485-1494, 2015 | 257 | 2015 |
| Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension N Afdhal, GT Everson, JL Calleja, GW McCaughan, J Bosch, DM Brainard, ... Journal of viral hepatitis 24 (10), 823-831, 2017 | 152* | 2017 |
| Decrease in hepatic CD56+ T cells and Vα24+ natural killer T cells in chronic hepatitis C viral infection T Deignan, MP Curry, DG Doherty, L Golden-Mason, Y Volkov, S Norris, ... Journal of hepatology 37 (1), 101-108, 2002 | 148 | 2002 |
| Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for hepatitis C virus infection O El-Sherif, ZG Jiang, EB Tapper, KC Huang, A Zhong, A Osinusi, ... Gastroenterology 154 (8), 2111-2121. e8, 2018 | 147 | 2018 |
| Integration of palliative care in end-stage liver disease and liver transplantation J Potosek, M Curry, M Buss, E Chittenden Journal of palliative medicine 17 (11), 1271-1277, 2014 | 146 | 2014 |
| Acute viral hepatitis MP Curry, S Chopra Principles and practice of infectious diseases. Philadelphia: Churchill …, 2005 | 145 | 2005 |
| Ledipasvir/Sofosbuvir with Ribavirin for the Treatment of HCV in Patients with Post Transplant Recurrence: Preliminary Results of a Prospective, Multicenter Study: 8 RK Reddy, GT Everson, SL Flamm, JM Denning, S Arterburn, ... Hepatology 60, 200A-201A, 2014 | 118 | 2014 |
| Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon J Levitsky, MI Fiel, JP Norvell, E Wang, KD Watt, MP Curry, S Tewani, ... Gastroenterology 142 (5), 1132-1139. e1, 2012 | 117 | 2012 |
| Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection MV Lin, ME Sise, M Pavlakis, BM Amundsen, D Chute, AE Rutherford, ... PLoS One 11 (7), e0158431, 2016 | 113 | 2016 |
Nezam AfdhalProfessor of Medicine, Harvard Medical SchoolVerified email at bidmc.harvard.edu
